TargED
Chemicals & Related Products · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Princetonlaan Vmc Building 6, Utrecht, U...Revenue
$14.5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About TargED
TargED Biopharmaceuticals B.V. is a biotechnology company that develops first-in-class biological drugs to improve the treatment of thrombosis. TargED Biopharmaceuticals was founded in 2018 and is based in the Netherlands.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TargED your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if TargED had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on TargED recently announced quarterly report
Product Launch: Get notified when TargED launches new products
Check if TargED has recently received funding, and reach out quickly before it becomes old news!
TargED, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if TargED is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at TargED
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once TargED has new funding data
Recommended Actions
Find VP level buyers at TargED
Find 3 more new buyers
Company Profile Activity
Activity Insights
TargED is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
TargED is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about TargED.
TargED financials insights
Gather financial insights about TargED, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$70.3M
TargED Tech Stack
A closer look at the technologies used by TargED
See more technologies
Most Recent Scoops
Open Position
Funding
Funding
Open Position
Open Position
TargED News & Media
Andera Partners supports TargED Biopharmaceuticals in EUR39m Series A financing
Andera Partners supports TargED Biopharmaceuticals in EUR39m Series A financing Submitted 22/02/2022 - 10:16am TargED Biopharmaceuticals (TargED), a private biotechnology company focused on developing improved treatments for thrombotic diseases, has raised Series A financing of EUR39 million to accelerate development of its lead compound, Microlyse. The financing was led by an international syndicate with equal contributions from Andera Partners, Fund+, Hadean Ventures, Inkef Capital and SunstonTargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking thrombolytic treatment to patients
UTRECHT, Netherlands, Feb. 22, 2022 /PRNewswire/ -- TargED Biopharmaceuticals ("TargED"), a private biotechnology company focused on developing improved treatments for thrombotic diseases, today announces it has raised Series A financing of EUR 39 million to accelerate development of its...
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TargED
Sign Up For FreeTo access detailed company insights
TargED Biopharmaceuticals B.V. is a biotechnology company that develops first-in-class biological drugs to improve the treatment of thrombosis. TargED Biopharmaceuticals was founded in 2018 and is based in the Netherlands.... Read More
